Home › Funds › Sands Capital Alternatives, LLC › SGP
Sands Capital Alternatives, LLC position in SGP
SPYGLASS PHARMA INC · Health Care
Sands Capital Alternatives, LLC reported holding 2,500,012 shares of SGP (SPYGLASS PHARMA INC) in its Q3 2026 13F filing — a position valued at US$65.0M, representing 9.62% of its reported portfolio and ranking #4 among its reported holdings. Sands Capital Alternatives, LLC has disclosed SGP holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Sands Capital Alternatives, LLC's SGP position evolved
Sands Capital Alternatives, LLC first disclosed a stake in SGP in Q1 2026 at 2,500,012 shares (US$64.8M). The position peaked in Q3 2026 at 2,500,012 shares, worth US$65.0M. Across 3 filings, Sands Capital Alternatives, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,500,012 shares valued at US$65.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.50M | $64.78M | New |
| Q2 2026 | 2.50M | $55.65M | Hold |
| Q3 2026 | 2.50M | $65.00M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SGP and 13F data
SGP (SPYGLASS PHARMA INC) is a Health Care company. 70 other funds we track also report a position in SGP — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$178.6M), NEA Management Company, LLC (US$164.6M), Samsara BioCapital, LLC (US$47.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SGP
- RA CAPITAL MANAGEMENT, L.P. 8.02M sh · $178.55M · Q2 2026
- NEA Management Company, LLC 7.39M sh · $164.55M · Q2 2026
- Samsara BioCapital, LLC 2.11M sh · $46.97M · Q2 2026
- Vestal Point Capital, LP 670.00K sh · $14.91M · Q2 2026
- Propel Bio Management, LLC 41.42K sh · $1.08M · Q3 2026
More on Sands Capital Alternatives, LLC
FAQ
How long has Sands Capital Alternatives, LLC held SGP?
Sands Capital Alternatives, LLC has disclosed SGP holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Sands Capital Alternatives, LLC's current position in SGP?
As of Q3 2026, Sands Capital Alternatives, LLC holds 2.50M shares of SGP (SPYGLASS PHARMA INC), valued at $65.00M, representing 9.62% of its reported portfolio and ranking #4.
Has Sands Capital Alternatives, LLC been buying or selling SGP?
In the latest 13F filing (Q3 2026), Sands Capital Alternatives, LLC held unchanged its position in SGP. The position peaked in Q3 2026 at 2.50M shares.
Which other funds hold SGP?
Other major institutional holders of SGP include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Samsara BioCapital, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.